HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. (Q43130032)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228817%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228817%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228817%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Julià Blanco

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228817%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Javier Martinez-Picado

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228817%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Maria José Buzon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228817%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Marta Massanella

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228817%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Viktor Dahl

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228817%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Bonaventura Clotet Sala

13

object named as

Bonaventura Clotet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228817%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Josep M Llibre

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228817%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Anna Esteve

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228817%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Josep M Gatell

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228817%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Pere Domingo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228817%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Roger Paredes

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228817%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Mark Sharkey

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228817%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Sarah Palmer

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228817%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Mario Stevenson

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228817%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

English

0 references

publication date

14 March 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228817%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228817%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228817%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

460-465

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228817%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20228817%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nm.2111

19 January 2020

exact match

0 references

cites work

Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years

1 reference

12 December 2020

Ablation of thymic export causes accelerated decay of naive CD4 T cells in the periphery because of activation by environmental antigen

1 reference

12 December 2020

Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART

1 reference

12 December 2020

Human immunodeficiency virus type 1 genetic evolution in patients with prolonged suppression of plasma viremia

1 reference

12 December 2020

The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.

1 reference

12 December 2020

HIV rebounds from latently infected cells, rather than from continuing low-level replication

1 reference

12 December 2020

In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA.

1 reference

12 December 2020

Lack of evidence for protease evolution in HIV-1-infected patients after 2 years of successful highly active antiretroviral therapy.

1 reference

12 December 2020

Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection

1 reference

12 December 2020

Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of

1 reference

12 December 2020

Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy.

1 reference

12 December 2020

T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy

1 reference

12 December 2020

Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads

1 reference

12 December 2020

Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions

1 reference

12 December 2020

Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy

1 reference

12 December 2020

Intensification of a suppressive HAART regimen increases CD4 counts and decreases CD8+ T-cell activation

1 reference

12 December 2020

Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus

1 reference

12 December 2020

Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination

1 reference

12 December 2020

Analysis of early human immunodeficiency virus type 1 DNA synthesis by use of a new sensitive assay for quantifying integrated provirus

1 reference

12 December 2020

Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells

1 reference

12 December 2020

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

1 reference

12 December 2020

Treatment implications of the latent reservoir for HIV-1.

1 reference

12 December 2020

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

1 reference

12 December 2020

Decay characteristics of HIV-1-infected compartments during combination therapy

1 reference

12 December 2020

Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection

1 reference

12 December 2020

HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir

1 reference

12 December 2020

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

1 reference

12 December 2020

Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazoles

1 reference

12 December 2020

HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells

1 reference

12 December 2020

Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.

1 reference

12 December 2020

New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma

1 reference

12 December 2020

Viral evolution during structured treatment interruptions in chronically human immunodeficiency virus-infected individuals

1 reference

12 December 2020